We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting

By LabMedica International staff writers
Posted on 24 Mar 2023

Conventional laboratory-based tests may require several days or weeks to generate results. More...

Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour, making results more accessible.

The Genomadix Cube from Genomadix (Ottawa, Canada) is a portable molecular analyzer that employs the gold standard Polymerase Chain Reaction (PCR) technique, delivering accurate outcomes without the need for a full-service laboratory. This decentralized testing option is particularly useful for remote industries and communities where access to a complete lab is limited. The PCR molecular diagnostic instrument generates top-quality results outside of a lab setting and is capable of testing for genetic, infectious disease, and environmental targets on a sample-to-result platform.

Collected samples are placed into a disposable DNA test cartridge, which is then inserted into the analyzer. Once inside, the cartridge extracts the DNA/RNA and produces millions of copies using the PCR process. An optical system detects the amplified fluorescence, and algorithms automatically generate a test outcome. The analyzer's portability, user-friendliness, and real-time processing capabilities allow for the swift generation of critical results.

Related Links:
Genomadix 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Manual Pipetting Aid
Pipette Controllers macro
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.